STRS Ohio’s Strongbridge Biopharma plc. SBBP Stock Holding History

STRS Ohio’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-179,000	Closed	-$494K	–	2512
2021 Q1	$494K	Hold	179,000	–	–	﹤0.01%	1573
2020 Q4	$434K	Hold	179,000	–	–	﹤0.01%	1531
2020 Q3	$375K	Buy	179,000 +77,900	+77%	+$263K	﹤0.01%	1482
2020 Q2	$382K	Buy	+101,100	New	+$303K	﹤0.01%	1449
2018 Q2	–	Sell	-6,400	Closed	-$56K	–	2215
2018 Q1	$56K	Hold	6,400	–	–	﹤0.01%	1724
2017 Q4	$46K	Hold	6,400	–	–	﹤0.01%	1759
2017 Q3	$44K	Hold	6,400	–	–	﹤0.01%	1804
2017 Q2	$45K	Buy	+6,400	New	+$29.6K	﹤0.01%	1811

Other funds holding SBBP

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

STRS Ohio's SBBP Position: Q2 2021 in Review

STRS Ohio sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 179,000 shares — an estimated $494K sold.

STRS Ohio first reported a position in SBBP in Q2 2017 and held it in 8 quarters. The position peaked at $494K in Q1 2021. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

STRS Ohio reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
STRS Ohio sold 179,000 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $494K.
STRS Ohio first reported a position in Strongbridge Biopharma plc. in Q2 2017 and held it in 8 quarters.
STRS Ohio's Strongbridge Biopharma plc. position peaked at $494K in Q1 2021.
59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.